Assembly Biosciences Inc [ASMB] stock prices are up 2.61% to $36.18 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ASMB shares have gain 4.57% over the last week, with a monthly amount drifted -1.50%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Assembly Biosciences Inc [NASDAQ: ASMB] stock has seen the most recent analyst activity on September 24, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $38. On March 25, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $31 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $35 on September 20, 2024. H.C. Wainwright initiated its recommendation with a Neutral and recommended $3.50 as its price target on September 13, 2021. William Blair downgraded its rating to Mkt Perform for this stock on September 02, 2021. In a note dated March 23, 2021, SVB Leerink downgraded an Mkt Perform rating on this stock.
The stock price of Assembly Biosciences Inc [ASMB] has been fluctuating between $7.75 and $39.71 over the past year. Currently, Wall Street analysts expect the stock to reach $39 within the next 12 months. Assembly Biosciences Inc [NASDAQ: ASMB] shares were valued at $36.18 at the most recent close of the market. An investor can expect a potential return of 7.79% based on the average ASMB price forecast.
Analyzing the ASMB fundamentals
The Assembly Biosciences Inc [NASDAQ:ASMB] reported sales of 37.19M for trailing twelve months, representing a surge of 57.62%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -1.84%, Pretax Profit Margin comes in at -1.65%, and Net Profit Margin reading is -1.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -1.49 and Total Capital is -1.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.48 points at the first support level, and at 32.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.44, and for the 2nd resistance point, it is at 40.69.
Ratios To Look Out For
It’s worth pointing out that Assembly Biosciences Inc [NASDAQ:ASMB]’s Current Ratio is 4.44. Further, the Quick Ratio stands at 4.44, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 15.39, the price to book ratio is 3.13.
Transactions by insiders
Recent insider trading involved McHutchison John G, Director, that happened on Mar 31 ’25 when 757.0 shares were sold. Principal Accounting Officer, Bjorkquist Jeanette M completed a deal on Mar 31 ’25 to sell 180.0 shares. Meanwhile, CEO and President Okazaki Jason A sold 355.0 shares on Mar 31 ’25.
